CAXTON CORP
Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q2 2025 ▲▼ | Q3 2025 ▲▼ | Change ▲▼ | Q2 2025 ▲▼ | Q3 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| REZOLUTE INC | 1,603,986 | 1,986,818 | +382,832 | 7,153,778 | 18,676,089 | 81.70% | +11,522,311 |
| SPDR GOLD TR(GLD) | 4,952 | 7,286 | +2,334 | 1,509,540 | 2,589,936 | 11.33% | +1,080,396 |
| MIND MEDICINE MINDMED INC | 34,073 | 27,011 | -7,062 | 221,134 | 318,459 | 1.39% | +97,325 |
| COMPASS THERAPEUTICS INC | 43,465 | 53,503 | +10,038 | 113,010 | 187,260 | 0.82% | +74,250 |
| BICARA THERAPEUTICS INC | 10,941 | 10,941 | 0 | 101,643 | 172,760 | 0.76% | +71,117 |
| KYVERNA THERAPEUTICS INC | 22,981 | 22,981 | 0 | 70,552 | 137,887 | 0.60% | +67,335 |
| LEXEO THERAPEUTICS INC | 17,332 | 17,332 | 0 | 69,674 | 115,084 | 0.50% | +45,410 |
| SAB BIOTHERAPEUTICS INC | 0 | 10,935 | +10,935 | 0 | 21,979 | 0.10% | +21,979 |
| BERKSHIRE HATHAWAY INC DEL | 632 | 651 | +19 | 307,040 | 327,454 | 1.43% | +20,414 |
| CONTEXT THERAPEUTICS INC | 18,403 | 18,403 | 0 | 12,058 | 17,829 | 0.08% | +5,771 |
| ENLIVEN THERAPEUTICS INC | 13,097 | 13,097 | 0 | 262,736 | 268,106 | 1.17% | +5,370 |
| INHIBIKASE THERAPEUTICS INC | 16,393 | 16,393 | 0 | 31,966 | 26,557 | 0.12% | -5,409 |